FibroBiologics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Net Income	-19.06	-5.12	-1.58
Depreciation & Amortization	0.44	0.09	0
Share-Based Compensation	1.77	0.27	0
Other Operating Activities	7.88	0.7	0.17
Operating Cash Flow	-6.4	-4.07	-1.41
Capital Expenditures	-0.5	0	0
Investing Cash Flow	-0.5	0	0
Debt Issued / Paid	0.3	3.78	1.53
Other Financing Activities	13.49	2.15	0.29
Financing Cash Flow	13.79	5.93	1.82
Net Cash Flow	6.9	1.86	0.41
Free Cash Flow	-6.9	-4.07	-1.41
Free Cash Flow Per Share	-0.24	-0.14	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).